Fentanyl

"Fentanyl" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Descriptor ID	D005283
MeSH Number(s)	D03.383.621.265
Concept/Terms	Fentanyl Fentanyl Phentanyl Fentanest Fentanest Fentanyl Citrate Fentanyl Citrate R-4263 R-4263 R 4263 R4263 Sublimaze Sublimaze Transmucosal Oral Fentanyl Citrate Transmucosal Oral Fentanyl Citrate Duragesic Duragesic Durogesic Fentora Fentora

Below are MeSH descriptors whose meaning is more general than "Fentanyl".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Piperidines [D03.383.621]
Fentanyl [D03.383.621.265]

Below are MeSH descriptors whose meaning is related to "Fentanyl".

Below are MeSH descriptors whose meaning is more specific than "Fentanyl".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fentanyl" by people in this website by year, and whether "Fentanyl" was a major or minor topic of these publications.

Bar chart showing 94 publications over 26 distinct years, with a maximum of 10 publications in 2022 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	1	0	1
1998	0	1	1
2000	1	0	1
2002	0	1	1
2004	2	1	3
2005	0	3	3
2006	3	1	4
2007	2	2	4
2008	0	1	1
2009	1	1	2
2010	2	1	3
2011	1	0	1
2012	0	3	3
2013	1	0	1
2014	1	2	3
2015	5	1	6
2016	4	1	5
2017	3	1	4
2018	4	0	4
2019	1	2	3
2020	0	1	1
2021	1	8	9
2022	7	3	10
2023	2	6	8
2024	4	6	10

Below are the most recent publications written about "Fentanyl" by people in Profiles.

Dicker F, Lothet E, Schwarz E, Aldy K, Brent J, Wax P, Culbreth R, Campleman S, Krotulski A, Logan B, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Hughes A, Hendrickson RG, Meaden CW, Manini AF. Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohort. Am J Emerg Med. 2025 Mar; 89:169-173.

View in: PubMed
Cieri G, Mohr ALA, Fogarty M, Chan-Hosokawa A, Logan BK. Four-year evaluation of drug-impaired driving drug concentrations. J Anal Toxicol. 2024 Nov 15; 48(9):641-652.

View in: PubMed
London K, Li Y, Kahoud JL, Cho D, Mulholland J, Roque S, Stugart L, Gillingham J, Borne E, Slovis B. Tranq Dope: Characterization of an ED cohort treated with a novel opioid withdrawal protocol in the era of fentanyl/xylazine. Am J Emerg Med. 2024 Nov; 85:130-139.

View in: PubMed
Dela Cruz AM, Egan D, Baker SE, Sadler JZ. When Are "Paraphernalia" Critical Medical Supplies? AMA J Ethics. 2024 Jul 01; 26(7):E527-533.

View in: PubMed
Bazazi AR, Low P, Gomez BO, Snyder H, Hom JK, Soran CS, Zevin B, Mason M, Graterol J, Coffin PO. Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events. J Urban Health. 2024 Apr; 101(2):245-251.

View in: PubMed
Hewes MP, Papsun DM, Logan BK, Krotulski AJ. Determination of fentanyl contamination on United States paper currency by LC-QQQ-MS. J Anal Toxicol. 2024 Mar 28; 48(3):141-149.

View in: PubMed
Cieri G, Mohr ALA, Mastrovito R, Logan BK. Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA). J Anal Toxicol. 2024 Mar 28; 48(3):191-196.

View in: PubMed
Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings. Ann Emerg Med. 2024 Jul; 84(1):20-28.

View in: PubMed
Reed MK, Borne E, Esteves Camacho T, Kelly M, Rising KL. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking. Harm Reduct J. 2024 01 30; 21(1):26.

View in: PubMed
Reed MK, Siegler A, Esteves Camacho T, London K, Schaeffer K, Rising KL. Making Harm Reduction More Accessible: Fentanyl Test Strip Awareness and Attitudes among Emergency Department Patients Who Use Drugs. Subst Use Misuse. 2024; 59(3):398-404.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement